ロード中...
Checkpoint inhibition and CAR T cells for the Treatment of Glioblastoma
INTRODUCTION: Glioblastoma (GBM) is a highly aggressive brain tumor and is one of the most lethal human cancers. Chimeric antigen receptor (CAR) T cell therapy has markedly improved survival in previously incurable disease; however, this vanguard treatment still faces challenges in GBM. Likewise, ch...
保存先:
| 出版年: | Expert Opin Biol Ther |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7202971/ https://ncbi.nlm.nih.gov/pubmed/32027536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14712598.2020.1727436 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|